 |
인쇄하기
취소
|
Drug Administration Subcommittee faced difficulties in selection of items to test bioequivalency.
The Drug Administration Subcommittee could not make any conclusion regarding the item selection of bioequivalency test and other disputed issues during the meeting on Aug. 30.
The Subcommittee failed to reach any conclusion in the meeting over the test and its method to prove an equivalent drug efficacy such as bioequivalent test, disintegration test and dissolution test that were earlier s...
The Subcommittee failed to reach any conclusion in the meeting over the test and its method to prove an equivalent drug efficacy such as bioequivalent test, disintegration test and dissolution test that were earlier s...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.